论文信息 - SKLB1002, a novel inhibitor of VEGF receptor 2 signaling, induces vascular normalization to improve systemically administered chemotherapy efficacy. - 字舞流文

SKLB1002, a novel inhibitor of VEGF receptor 2 signaling, induces vascular normalization to improve systemically administered chemotherapy efficacy.

G. Shen | X. Chen | H. Deng | T. Du | S. Yang | W. Li | S. Zhang | L. Dai | G. Shi | Y. Li | Y. Wei | R. Zheng | X. Su | Y. Wei | S. Yang | G. Shen | Shujun Zhang